Department of Pathology Microbiology and Immunology Archive — Page 10 of 30
-
November 11, 2021
CRISPR screen identifies new anti-inflammatory drug target
A novel CRISPR screen developed by Vanderbilt researchers identified a promising new target for anti-inflammatory therapeutics. -
October 28, 2021
VUMC researchers a step closer to broad ebolavirus protection
-
October 13, 2021
Diagnostic Laboratory Services set for relocation, expansion
Vanderbilt's Diagnostic Laboratory Services are undergoing a major relocation and expansion project. -
October 5, 2021
AstraZeneca seeks emergency approval for COVID-19 antibodies isolated at VUMC
Biopharmaceutical company AstraZeneca has requested emergency use authorization (EUA) from the U.S. Food and Drug Administration for a long-acting antibody combination originally developed at Vanderbilt University Medical Center to protect against COVID-19. -
September 30, 2021
Molecular imaging of C. diff infection
C. difficile — the leading cause of hospital-associated intestinal infections — induces a rapid influx of bile acids into the gut, which could provide a novel target for blocking infection. -
September 22, 2021
“Ultra-potent” antibody against COVID-19 variants isolated at VUMC
A technology developed at Vanderbilt has led to the discovery of an “ultra-potent” monoclonal antibody against multiple variants of SARS-CoV-2, the virus responsible for COVID-19, including the delta variant. -
September 10, 2021
Caught in a web: study reveals that immune cells cooperate to trap and kill bacteria
Vanderbilt researchers have identified a new antibacterial mechanism that could inspire novel strategies for combating staph and other extracellular bacterial pathogens.